Without an approved COVID-19 treatment, physicians are prescribing malaria drugs whose effectiveness hasn’t been proven—drawing condemnations from health experts.  2 former US FDA leaders have objected to the Trump administration’s emergency use authorization of…

COVID-19’s lethal invasion in late 2019 has turned the world inside out. Yet, another disease, tuberculosis, has been plaguing humans since the Upper Paleolithic era, some 20,000 years ago. In fact, many infection-prevention precautions promoted for the coronavirus—coughing…

For $115.5 billion, preventable maternal deaths could be ended by 2030, according to a UN report presented yesterday at the International Conference on Population and Development, Thomson Reuters Foundation reports. And for $264 billion, countries could end maternal deaths…

Horseshoe crabs’ prized blue blood is ubiquitous in medical safety tests that detect contamination in IV drugs and medical implants. Their copper-rich blood clots around potentially dangerous molecules in bacteria, which scientists leveraged to save patients from toxic…

Prison and police services in Basra, Iraq are stretched to the brink as scores of dealers and users are put behind bars, most of them unemployed and under 25. Crystal meth is the dominant drug. The city’s massive oil wealth stands in stark contrast to its poor living…

Excessive, unnecessary use of medically important antibiotics in livestock production is spurring antibiotic resistance in animals and humans, confirms a Natural Resources Defense Council (NRDC) report published this week.

Although malaria deaths have been nearly halved since 2000, the global health community is hardly in a celebratory mood on this World Malaria Day. The reason: Progress against malaria has recently stalled. “We are now at a turning point, warned WHO Director-General Tedros…

India’s pharmaceutical industry is churning out drugs to treat the country’s 70 million diabetics. Many are questionable combination pills hitting the shelves without clinical trials. An analysis of India’s regulatory procedures found fixed-dose combination drugs (FDCs)…

It’s ever-harder to do justice to the gravity of the US opioid crisis, but TIME goes some way in its first-ever issue dedicated to a single topic. Tracking users, first responders, families, funerals and recoveries, James Nachtwey’s haunting photos are nothing short of war…

Editor’s Note: This week we will highlight 5 takes on how we can reduce drug prices while preserving robust research and development, from the fall issue of Hopkins Bloomberg Public Health Magazine. Read the complete set here.